Revenuefromcontractwithcustomerincludingassessedtax was Acro Biomedical’s largest revenue line in fiscal 2019, bringing in $1.27M of $1.35M (94%).
| Breakdown | FY 2018 | FY 2019 |
|---|---|---|
| Revenuefromcontractwithcustomerincludingassessedtax | $4.27M | $1.27M |
| Customer C | — | $80.00K |
| Total | $4.27M | $1.35M |
Acro Biomedical brought in $1.35M from its two revenue lines in fiscal 2019, the year ended September 30, 2019. Acro Biomedical regrouped these revenue lines after fiscal 2018, so the total does not compare directly with that year's $4.27M. Revenuefromcontractwithcustomerincludingassessedtax was the largest at $1.27M (94.1%), ahead of Customer C at $80.00K (5.9%).
Acro Biomedical began breaking out Customer C in fiscal 2019, when it brought in $80.00K.
Acro Biomedical (ACBM) reports its revenue by breakdown. In fiscal 2019, Revenuefromcontractwithcustomerincludingassessedtax was its largest revenue line, bringing in $1.27M (94.1% of the total), followed by Customer C at $80.00K (5.9%).
Revenuefromcontractwithcustomerincludingassessedtax was Acro Biomedical's largest revenue line in fiscal 2019, bringing in $1.27M, or 94.1% of the $1.35M total across its two revenue lines.
Every figure comes from Acro Biomedical's annual financial filings, as reported. Each line keeps the name Acro Biomedical gives it, and years follow its fiscal calendar.
Acro Biomedical's revenue by breakdown goes back to fiscal 2018, with figures through fiscal 2019. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.